A first-in-human study of INS-3001 in Vascular calcification
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2018
Price : $35 *
At a glance
- Drugs INS 3001 (Primary)
- Indications Vascular calcification
- Focus Adverse reactions; First in man
- 02 Nov 2018 Trial focus and the subjects gender are assumed. There may be more than one first in human study. As of now creating only one study.
- 01 Nov 2018 New trial record
- 26 Oct 2018 According to an Inositec media release, the IND-enabling studies are ongoing and will initiate this study in 2019.